
Director, Clinical Operations Asset Lead, Late-Phase Lung Oncology
GSKLead global late-phase lung oncology programs at GSK, shaping clinical operations strategy and study delivery. Oversee risk management, operational planning, and readiness for a Biologics License Application (BLA).